Related references
Note: Only part of the references are listed.Intracranial injection of PEG-PEI/ROCK II-siRNA improves cognitive impairment in a mouse model of Alzheimer's disease
Xiaojun Wen et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE (2014)
Factors Influencing the Retrograde Labeling of Retinal Ganglion Cells with Fluorogold in an Animal Optic Nerve Crush Model
Tzu-Lun Huang et al.
OPHTHALMIC RESEARCH (2014)
ROCK2 is a major regulator of axonal degeneration, neuronal death and axonal regeneration in the CNS
J. C. Koch et al.
CELL DEATH & DISEASE (2014)
Spatiotemporal patterns of Gem expression after rat spinal cord injury
Hai Wen et al.
BRAIN RESEARCH (2013)
Glaucoma and optic nerve repair
Heike Diekmann et al.
CELL AND TISSUE RESEARCH (2013)
Rho/ROCK pathway is essential to the expansion, differentiation, and morphological rearrangements of human neural stem/progenitor cells induced by lysophosphatidic acid
Frisca Frisca et al.
JOURNAL OF LIPID RESEARCH (2013)
Increased expression of Gem after rat sciatic nerve injury
Youhua Wang et al.
JOURNAL OF MOLECULAR HISTOLOGY (2013)
Involvement of transcription initiation factor IIB in the light-induced death of rat retinal ganglion cells in vivo
Aimin Sang et al.
JOURNAL OF MOLECULAR HISTOLOGY (2013)
The member of high temperature requirement family HtrA2 participates in neuronal apoptosis after intracerebral hemorrhage in adult rats
Huiqing Sun et al.
JOURNAL OF MOLECULAR HISTOLOGY (2013)
Pharmacologic Inhibition of ROCK2 Suppresses Amyloid-β Production in an Alzheimer's Disease Mouse Model
Jeremy H. Herskowitz et al.
JOURNAL OF NEUROSCIENCE (2013)
Misguidance and modulation of axonal regeneration by Stat3 and Rho/ROCK signaling in the transparent optic nerve
V. Pernet et al.
CELL DEATH & DISEASE (2013)
Systematic review and stratified meta-analysis of the efficacy of RhoA and Rho kinase inhibitors in animal models of ischaemic stroke
Hanna M. Vesterinen et al.
SYSTEMATIC REVIEWS (2013)
Inhibition of rho kinase enhances survival of dopaminergic neurons and attenuates axonal loss in a mouse model of Parkinson's disease
Lars Toenges et al.
BRAIN (2012)
Rho-Kinase Inhibitor, Fasudil, Prevents Neuronal Apoptosis via the Akt Activation and PTEN Inactivation in the Ischemic Penumbra of Rat Brain
Jianhua Wu et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2012)
Neuroprotective effects of Caffeic acid phenethyl ester on experimental traumatic brain injury in rats
Memduh Kerman et al.
JOURNAL OF MOLECULAR HISTOLOGY (2012)
Involvement of microglial RhoA/Rho-Kinase pathway activation in the dopaminergic neuron death. Role of angiotensin via angiotensin type 1 receptors
Begona Villar-Cheda et al.
NEUROBIOLOGY OF DISEASE (2012)
Preventive and therapeutic effects of the selective Rho-kinase inhibitor fasudil on experimental autoimmune neuritis
Arnold Angelo M. Pineda et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2011)
Sustained Analgesic Effect of the Rho Kinase Inhibitor AS1892802 in Rat Models of Chronic Pain
Eiji Yoshimi et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2010)
Combined inhibition of Cdk5 and ROCK additively increase cell survival, but not the regenerative response in regenerating retinal ganglion cells
Christina Bermel et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2009)
Antiepileptic effects of two Rho-kinase inhibitors, Y-27632 and fasudil, in mice
S. Y. Inan et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Gem associates with ezrin and acts via the Rho-GAP protein gmip to down-regulate the Rho pathway
Anastassia Hatzoglou et al.
MOLECULAR BIOLOGY OF THE CELL (2007)
Wide therapeutic time window for fasudil neuroprotection against ischemia-induced delayed neuronal death in gerbils
Shin-ichi Satoh et al.
BRAIN RESEARCH (2007)
Share Paper
